Fund shareholders of Regeneron Pharmaceuticals, Inc.
ISIN US75886F1075 · United States · LEI 549300RCBFWIRX3HYQ56
- Fund shareholders
- 1,130
- Of which ETFs
- 315 815 other funds
- Value held
- 30.8B $ 4.1B SEK · 102.9M €
1,130 funds hold this company. This table lists the 1,113 that declare it in a regulatory filing. The other 17 publish their holdings in their own reports. They are not in the table.
| Fund | Shares | Value | Weight in fund | |
|---|---|---|---|---|
| Invesco Comstock Portfolio Brighthouse Funds Trust I | 23,212 | 17.9M $ | 0.99 % | as of Mar 31, 2026 ↗ |
| VANGUARD S&P 500 VALUE INDEX FUND VANGUARD ADMIRAL FUNDS | 23,099 | 18.1M $ | 0.28 % | as of Feb 28, 2026 ↗ |
| T. Rowe Price Health Sciences Portfolio T. ROWE PRICE EQUITY SERIES, INC. | 23,001 | 17.8M $ | 2.68 % | as of Mar 31, 2026 ↗ |
| U.S. LARGE COMPANY PORTFOLIO DIMENSIONAL INVESTMENT GROUP INC | 22,957 | 16.2M $ | 0.12 % | as of Apr 30, 2026 ↗ |
| EQUITY INDEX PORTFOLIO VANGUARD VARIABLE INSURANCE FUNDS | 22,573 | 17.4M $ | 0.14 % | as of Mar 31, 2026 ↗ |
| VANGUARD ESG U.S. STOCK ETF VANGUARD WORLD FUND | 22,565 | 17.6M $ | 0.15 % | as of Feb 28, 2026 ↗ |
| iShares MSCI USA Min Vol Factor ETF iShares Trust | 22,564 | 16M $ | 0.07 % | as of Apr 30, 2026 ↗ |
| JPMorgan Equity Index Fund JPMorgan Trust II | 22,273 | 17.2M $ | 0.14 % | as of Mar 31, 2026 ↗ |
| Bridge Builder Large Cap Value Fund Bridge Builder Trust | 21,986 | 17M $ | 0.07 % | as of Mar 31, 2026 ↗ |
| Nuveen S&P 500 Index Fund TIAA-CREF Funds | 21,836 | 15.4M $ | 0.11 % | as of Apr 30, 2026 ↗ |
| AST Balanced Asset Allocation Portfolio Advanced Series Trust | 21,503 | 16.6M $ | 0.08 % | as of Mar 31, 2026 ↗ |
| LVIP SSGA S&P 500 Index Fund LINCOLN VARIABLE INSURANCE PRODUCTS TRUST | 21,322 | 16.5M $ | 0.14 % | as of Mar 31, 2026 ↗ |
| LargeCap S&P 500 Index Fund Principal Funds, Inc | 21,228 | 15M $ | 0.11 % | as of Apr 30, 2026 ↗ |
| Growth Fund AMERICAN FUNDS INSURANCE SERIES | 21,203 | 16.4M $ | 0.03 % | as of Mar 31, 2026 ↗ |
| Large-Cap Core Portfolio PACIFIC SELECT FUND | 21,180 | 16.4M $ | 0.82 % | as of Mar 31, 2026 ↗ |
| VANGUARD MEGA CAP INDEX FUND VANGUARD WORLD FUND | 21,132 | 16.5M $ | 0.16 % | as of Feb 28, 2026 ↗ |
| EQ/Equity 500 Index Portfolio EQ Advisors Trust | 20,880 | 16.1M $ | 0.14 % | as of Mar 31, 2026 ↗ |
| Putnam Dynamic Asset Allocation Balanced Fund Putnam Asset Allocation Funds | 20,841 | 16.1M $ | 0.55 % | as of Mar 31, 2026 ↗ |
| 500 Index Trust John Hancock Variable Insurance Trust | 20,679 | 16M $ | 0.14 % | as of Mar 31, 2026 ↗ |
| EQ/JPMorgan Value Opportunities Portfolio EQ Advisors Trust | 20,232 | 15.6M $ | 1.28 % | as of Mar 31, 2026 ↗ |
| Länsförsäkringar Global Index Länsförsäkringar Fondförvaltning AB | 20,120 | 148.1M SEK | 0.12 % | as of Mar 31, 2026 ↗ |
| NVIT J.P. Morgan U.S. Equity Fund Nationwide Variable Insurance Trust | 20,074 | 15.5M $ | 0.82 % | as of Mar 31, 2026 ↗ |
| iShares U.S. Equity Factor Rotation Active ETF BlackRock ETF Trust | 19,876 | 14.1M $ | 0.04 % | as of Apr 30, 2026 ↗ |
| Invesco V.I. Growth and Income Fund AIM Variable Insurance Funds (Invesco Variable Insurance Funds) | 19,814 | 15.3M $ | 1.22 % | as of Mar 31, 2026 ↗ |
| EQUITY INDEX FUND GuideStone Funds | 19,789 | 15.3M $ | 0.26 % | as of Mar 31, 2026 ↗ |
| Avantis U.S. Equity ETF American Century ETF Trust | 19,289 | 15.1M $ | 0.13 % | as of Feb 28, 2026 ↗ |
| T. Rowe Price U.S. Equity Research Fund T. Rowe Price U.S. Equity Research Fund, Inc. | 19,230 | 14.9M $ | 0.10 % | as of Mar 31, 2026 ↗ |
| THE HARTFORD HEALTHCARE FUND HARTFORD MUTUAL FUNDS, INC | 19,182 | 13.6M $ | 1.86 % | as of Apr 30, 2026 ↗ |
| JPMorgan U.S. Large Cap Core Plus Fund JPMorgan Trust I | 19,149 | 14.8M $ | 0.46 % | as of Mar 31, 2026 ↗ |
| State Street(R) SPDR(R) Portfolio S&P 1500(R) Composite Stock Market ETF SPDR SERIES TRUST | 19,085 | 14.7M $ | 0.13 % | as of Mar 31, 2026 ↗ |
| FT Vest Rising Dividend Achievers Target Income ETF First Trust Exchange-Traded Fund IV | 18,975 | 13.4M $ | 0.44 % | as of Apr 30, 2026 ↗ |
| Victory Value Fund Victory Portfolios III | 18,839 | 13.3M $ | 0.93 % | as of Apr 30, 2026 ↗ |
| First Trust US Equity Opportunities ETF First Trust Exchange-Traded Fund | 18,499 | 14.3M $ | 1.23 % | as of Mar 31, 2026 ↗ |
| Invesco V.I. Comstock Fund AIM Variable Insurance Funds (Invesco Variable Insurance Funds) | 18,393 | 14.2M $ | 0.99 % | as of Mar 31, 2026 ↗ |
| Invesco Equally-Weighted S&P 500 Fund AIM Counselor Series Trust (Invesco Counselor Series Trust) | 18,357 | 14.3M $ | 0.20 % | as of Feb 28, 2026 ↗ |
| Goldman Sachs Nasdaq-100 Premium Income ETF Goldman Sachs ETF Trust | 18,357 | 14.2M $ | 0.45 % | as of Mar 31, 2026 ↗ |
| iShares Future Exponential Technologies ETF iShares Trust | 18,211 | 12.9M $ | 0.33 % | as of Apr 30, 2026 ↗ |
| EQ/Large Cap Growth Managed Volatility Portfolio EQ Advisors Trust | 18,064 | 14M $ | 0.35 % | as of Mar 31, 2026 ↗ |
| Natixis Loomis Sayles Focused Growth ETF Natixis ETF Trust II | 17,924 | 13.8M $ | 1.99 % | as of Mar 31, 2026 ↗ |
| Invesco MSCI USA ETF Invesco Exchange-Traded Fund Trust II | 17,748 | 13.9M $ | 0.14 % | as of Feb 28, 2026 ↗ |
| U.S. Strategic Equity Fund RUSSELL INVESTMENT CO | 17,504 | 12.4M $ | 0.41 % | as of Apr 30, 2026 ↗ |
| DWS CROCI(R) U.S. Fund DEUTSCHE DWS INVESTMENT TRUST | 17,498 | 13.5M $ | 1.97 % | as of Mar 31, 2026 ↗ |
| Natixis U.S. Equity Opportunities Fund Natixis Funds Trust I | 17,338 | 13.4M $ | 1.14 % | as of Mar 31, 2026 ↗ |
| PSF Stock Index Portfolio Prudential Series Fund | 17,050 | 13.2M $ | 0.13 % | as of Mar 31, 2026 ↗ |
| VANGUARD RUSSELL 1000 INDEX FUND VANGUARD SCOTTSDALE FUNDS | 16,946 | 13.2M $ | 0.13 % | as of Feb 28, 2026 ↗ |
| iShares Russell Top 200 Value ETF iShares Trust | 16,804 | 13M $ | 0.38 % | as of Mar 31, 2026 ↗ |
| Invesco Biotechnology & Genome ETF Invesco Exchange-Traded Fund Trust | 16,684 | 11.8M $ | 4.77 % | as of Apr 30, 2026 ↗ |
| Transamerica JPMorgan Enhanced Index VP TRANSAMERICA SERIES TRUST | 16,634 | 12.9M $ | 0.50 % | as of Mar 31, 2026 ↗ |
| Baird Chautauqua Global Growth Fund Baird Funds Inc | 16,516 | 12.8M $ | 3.09 % | as of Mar 31, 2026 ↗ |
| Columbia Disciplined Core Fund Columbia Funds Series Trust II | 16,426 | 11.6M $ | 0.23 % | as of Apr 30, 2026 ↗ |
| JPMorgan Hedged Equity 3 Fund JPMorgan Trust IV | 16,377 | 12.7M $ | 0.48 % | as of Mar 31, 2026 ↗ |
| Empower S&P 500 Index Fund EMPOWER FUNDS, INC. | 16,334 | 12.6M $ | 0.14 % | as of Mar 31, 2026 ↗ |
| Venerable US Large Cap Strategic Equity Fund Venerable Variable Insurance Trust | 15,958 | 12.3M $ | 0.48 % | as of Mar 31, 2026 ↗ |
| Invesco S&P 500 Equal Weight Health Care ETF Invesco Exchange-Traded Fund Trust | 15,819 | 11.2M $ | 1.62 % | as of Apr 30, 2026 ↗ |
| MetLife Stock Index Portfolio Brighthouse Funds Trust II | 15,363 | 11.9M $ | 0.14 % | as of Mar 31, 2026 ↗ |
| Swedbank Robur Transfer 60 Swedbank Robur Fonder AB | 15,200 | 111.9M SEK | 0.25 % | as of Mar 31, 2026 ↗ |
| AST Large-Cap Growth Portfolio Advanced Series Trust | 14,973 | 11.6M $ | 0.17 % | as of Mar 31, 2026 ↗ |
| Schwab Health Care Fund SCHWAB CAPITAL TRUST | 14,943 | 10.6M $ | 1.72 % | as of Apr 30, 2026 ↗ |
| Direxion NASDAQ-100 Equal Weighted Index Shares Direxion Shares ETF Trust | 14,942 | 10.6M $ | 0.87 % | as of Apr 30, 2026 ↗ |
| AB Disruptors ETF AB Active ETFs, Inc. | 14,480 | 11.3M $ | 0.69 % | as of Feb 28, 2026 ↗ |
| Invesco V.I. Equity and Income Fund AIM Variable Insurance Funds (Invesco Variable Insurance Funds) | 14,170 | 10.9M $ | 0.79 % | as of Mar 31, 2026 ↗ |
| iShares Morningstar Mid-Cap Value ETF iShares Trust | 14,143 | 10M $ | 0.97 % | as of Apr 30, 2026 ↗ |
| Blackstone Alternative Multi-Strategy Fund Blackstone Alternative Investment Funds | 13,960 | 10.8M $ | 0.30 % | as of Mar 31, 2026 ↗ |
| AST Aggressive Asset Allocation Portfolio Advanced Series Trust | 13,916 | 10.8M $ | 0.10 % | as of Mar 31, 2026 ↗ |
| NEOS S&P 500(R) High Income ETF NEOS ETF Trust | 13,869 | 10.7M $ | 0.13 % | as of Mar 31, 2026 ↗ |
| Fidelity Flex 500 Index Fund Fidelity Concord Street Trust | 13,795 | 10.8M $ | 0.13 % | as of Feb 28, 2026 ↗ |
| Franklin U.S. Core Equity (IU) Fund Franklin Fund Allocator Series | 13,681 | 9.7M $ | 0.80 % | as of Apr 30, 2026 ↗ |
| Calvert U.S. Large Cap Value Responsible Index Fund Calvert Responsible Index Series, Inc. | 13,668 | 10.6M $ | 0.58 % | as of Mar 31, 2026 ↗ |
| Franklin Global Allocation Fund Franklin Fund Allocator Series | 13,662 | 10.6M $ | 0.38 % | as of Mar 31, 2026 ↗ |
| Handelsbanken USA Index Criteria Handelsbanken Fonder AB | 13,478 | 99.2M SEK | 0.23 % | as of Mar 31, 2026 ↗ |
| AST PGIM Aggressive Multi-Asset Portfolio Advanced Series Trust | 13,471 | 10.4M $ | 0.08 % | as of Mar 31, 2026 ↗ |
| Dimensional US Core Equity Market ETF Dimensional ETF Trust | 13,306 | 9.4M $ | 0.08 % | as of Apr 30, 2026 ↗ |
| Index 500 Stock Portfolio NORTHWESTERN MUTUAL SERIES FUND INC | 12,810 | 9.9M $ | 0.14 % | as of Mar 31, 2026 ↗ |
| JPMORGAN BETABUILDERS U.S. EQUITY ETF J.P. Morgan Exchange-Traded Fund Trust | 12,710 | 9M $ | 0.11 % | as of Apr 30, 2026 ↗ |
| Columbia Variable Portfolio - Disciplined Core Fund Columbia Funds Variable Series Trust II | 12,704 | 9.8M $ | 0.28 % | as of Mar 31, 2026 ↗ |
| Invesco Pharmaceuticals ETF Invesco Exchange-Traded Fund Trust | 12,647 | 8.9M $ | 2.68 % | as of Apr 30, 2026 ↗ |
| JPMorgan U.S. GARP Equity Fund JPMorgan Trust I | 12,497 | 9.7M $ | 0.53 % | as of Mar 31, 2026 ↗ |
| JNL/JPMorgan U.S. Value Fund JNL Series Trust | 12,437 | 9.6M $ | 0.74 % | as of Mar 31, 2026 ↗ |
| Dimensional US Large Cap Value ETF Dimensional ETF Trust | 12,424 | 8.8M $ | 0.15 % | as of Apr 30, 2026 ↗ |
| BlackRock Global Allocation Fund, Inc. BlackRock Global Allocation Fund, Inc. | 12,342 | 8.7M $ | 0.05 % | as of Apr 30, 2026 ↗ |
| Calvert U.S. Large Cap Core Responsible Index Fund Calvert Responsible Index Series, Inc. | 12,316 | 9.5M $ | 0.17 % | as of Mar 31, 2026 ↗ |
| AQR Style Premia Alternative Fund AQR Funds | 12,316 | 9.5M $ | 0.42 % | as of Mar 31, 2026 ↗ |
| EQ/500 Managed Volatility Portfolio EQ Advisors Trust | 12,217 | 9.4M $ | 0.13 % | as of Mar 31, 2026 ↗ |
| EQ/Common Stock Index Portfolio EQ Advisors Trust | 12,100 | 9.3M $ | 0.13 % | as of Mar 31, 2026 ↗ |
| Calamos Market Neutral Income Fund CALAMOS INVESTMENT TRUST/IL | 11,793 | 8.3M $ | 0.05 % | as of Apr 30, 2026 ↗ |
| U.S. Sustainability Core 1 Portfolio DFA INVESTMENT DIMENSIONS GROUP INC | 11,531 | 8.2M $ | 0.10 % | as of Apr 30, 2026 ↗ |
| Fidelity Blue Chip Growth K6 Fund Fidelity Securities Fund | 11,400 | 8.1M $ | 0.04 % | as of Apr 30, 2026 ↗ |
| Stock Index Fund VALIC Co I | 11,369 | 8.9M $ | 0.13 % | as of Feb 28, 2026 ↗ |
| Invesco Russell 1000 Dynamic Multifactor ETF Invesco Exchange-Traded Self-Indexed Fund Trust | 11,313 | 8.8M $ | 0.20 % | as of Feb 28, 2026 ↗ |
| Equity Index Portfolio PACIFIC SELECT FUND | 11,239 | 8.7M $ | 0.14 % | as of Mar 31, 2026 ↗ |
| Nasdaq-100 Index Fund SHELTON FUNDS | 11,166 | 8.7M $ | 0.44 % | as of Feb 28, 2026 ↗ |
| Applied Finance Select Fund World Funds Trust | 11,152 | 7.9M $ | 1.19 % | as of Apr 30, 2026 ↗ |
| Schwab Select Large Cap Growth Fund LAUDUS TRUST | 11,116 | 8.6M $ | 0.43 % | as of Mar 31, 2026 ↗ |
| Simplify Health Care ETF Simplify Exchange Traded Funds | 11,017 | 8.5M $ | 3.63 % | as of Mar 31, 2026 ↗ |
| Cambiar Opportunity Fund ADVISORS' INNER CIRCLE FUND | 11,000 | 7.8M $ | 2.37 % | as of Apr 30, 2026 ↗ |
| Fidelity Enhanced Large Cap Value ETF Fidelity Covington Trust | 10,967 | 8.5M $ | 0.32 % | as of Mar 31, 2026 ↗ |
| iShares Morningstar Mid-Cap ETF iShares Trust | 10,883 | 7.7M $ | 0.50 % | as of Apr 30, 2026 ↗ |
| Victory RS Large Cap Alpha Fund Victory Portfolios | 10,880 | 8.4M $ | 1.56 % | as of Mar 31, 2026 ↗ |
| JNL/Invesco Diversified Dividend Fund JNL Series Trust | 10,781 | 8.3M $ | 1.05 % | as of Mar 31, 2026 ↗ |
| LVIP American Century Ultra(R) Fund LINCOLN VARIABLE INSURANCE PRODUCTS TRUST | 10,667 | 8.2M $ | 0.72 % | as of Mar 31, 2026 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table ranks funds by number of shares. This one ranks them by the weight of the company in each fund.
| Fund | Weight in fund | |
|---|---|---|
| Direxion Daily Biotech Top 5 Bull 2X ETF Direxion Shares ETF Trust | 8.55 % | as of Apr 30, 2026 ↗ |
| VanEck Biotech ETF VanEck ETF Trust | 7.51 % | as of Mar 31, 2026 ↗ |
| iShares Biotechnology ETF iShares Trust | 7.21 % | as of Mar 31, 2026 ↗ |
| Amplify Weight Loss Drug & Treatment ETF Amplify ETF Trust | 6.77 % | as of Mar 31, 2026 ↗ |
| Invesco Nasdaq Biotechnology ETF Invesco Exchange-Traded Fund Trust II | 6.03 % | as of Feb 28, 2026 ↗ |
| Nomura Healthcare Fund Delaware Group Equity Funds IV | 5.46 % | as of Mar 31, 2026 ↗ |
| Longleaf Partners Global Fund Longleaf Partners Funds Trust | 4.83 % | as of Mar 31, 2026 ↗ |
| Longleaf Partners Fund Longleaf Partners Funds Trust | 4.82 % | as of Mar 31, 2026 ↗ |
| Invesco Biotechnology & Genome ETF Invesco Exchange-Traded Fund Trust | 4.77 % | as of Apr 30, 2026 ↗ |
| LIVE OAK HEALTH SCIENCES FUND Oak Associates Funds | 4.66 % | as of Apr 30, 2026 ↗ |
Quarter after quarter
Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.
| Quarter | Shareholders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q2 | 1,017 | +69 | 40,397,822 | +6.2 % |
| 2026Q1 | 948 | +29 | 38,042,108 | +7.4 % |
| 2025Q4 | 919 | +31 | 35,427,572 | -7.9 % |
| 2025Q3 | 888 | -76 | 38,464,142 | -8.2 % |
| 2025Q2 | 964 | +29 | 41,897,672 | -1.9 % |
| 2025Q1 | 935 | -91 | 42,717,919 | -8.6 % |
| 2024Q4 | 1,026 | -2 | 46,741,888 | -1.0 % |
| 2024Q3 | 1,028 | +4 | 47,228,499 | +0.0 % |
| 2024Q2 | 1,024 | +25 | 47,204,916 | +4.4 % |
| 2024Q1 | 999 | +5 | 45,210,158 | -5.5 % |
| 2023Q4 | 994 | 47,828,710 |
Institutional managers
1,377 managers declare this company to the SEC (Form 13F). The table shows the 25 largest.
| Manager | Shares | Value | |
|---|---|---|---|
| BlackRock, Inc. | 8,947,735 | 6.9B $ | as of Mar 31, 2026 |
| STATE STREET CORP | 4,664,478 | 3.6B $ | as of Mar 31, 2026 |
| Dodge & Cox | 4,458,238 | 3.4B $ | as of Mar 31, 2026 |
| JPMORGAN CHASE & CO | 4,311,806 | 3.2B $ | as of Mar 31, 2026 |
| FRANKLIN RESOURCES INC | 2,722,071 | 2.1B $ | as of Mar 31, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | 2,607,732 | 2B $ | as of Mar 31, 2026 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 2,177,527 | 1.7M $ | as of Mar 31, 2026 |
| Nuveen, LLC | 2,065,064 | 1.6B $ | as of Mar 31, 2026 |
| LOOMIS SAYLES & CO L P | 1,912,310 | 1.5B $ | as of Mar 31, 2026 |
| WELLINGTON MANAGEMENT GROUP LLP | 1,837,459 | 1.4B $ | as of Mar 31, 2026 |
| Invesco Ltd. | 1,724,478 | 1.3B $ | as of Mar 31, 2026 |
| FMR LLC | 1,518,192 | 1.2B $ | as of Mar 31, 2026 |
| Capital World Investors | 1,419,000 | 1.1B $ | as of Mar 31, 2026 |
| MORGAN STANLEY | 1,319,329 | 1B $ | as of Mar 31, 2026 |
| GOLDMAN SACHS GROUP INC | 1,300,558 | 1B $ | as of Mar 31, 2026 |
| AQR CAPITAL MANAGEMENT LLC | 1,231,008 | 946M $ | as of Mar 31, 2026 |
| BANK OF AMERICA CORP /DE/ | 1,189,584 | 919.1M $ | as of Mar 31, 2026 |
| Amundi | 1,009,798 | 780.2M $ | as of Mar 31, 2026 |
| NORTHERN TRUST CORP | 941,941 | 727.8M $ | as of Mar 31, 2026 |
| TWO SIGMA INVESTMENTS, LP | 812,236 | 627.6M $ | as of Mar 31, 2026 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 804,508 | 621.6M $ | as of Mar 31, 2026 |
| Bank of New York Mellon Corp | 765,411 | 591.4M $ | as of Mar 31, 2026 |
| Legal & General Group Plc | 732,054 | 565.6M $ | as of Mar 31, 2026 |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | 723,621 | 559.1M $ | as of Mar 31, 2026 |
| DEUTSCHE BANK AG\ | 625,388 | 483.2M $ | as of Mar 31, 2026 |
Declared shareholders of Regeneron Pharmaceuticals, Inc.
There is 1 beneficial ownership filing. These stakes do not add up. An asset manager that files includes its own funds, which already appear among the funds on this page.
| Shareholder | Declared stake | Shares | |
|---|---|---|---|
| Vanguard Capital Management | 7.37 % | 7,660,810 | as of Mar 31, 2026 · SCHEDULE 13G |
Funds holding the debt of Regeneron Pharmaceuticals, Inc.
130 funds declare 156 bond lines of this company. The table shows the 25 largest holdings. The amount is the one the fund files. It is not a share of the debt, because no regulator publishes the amount outstanding in open access.
Cite this page
Titelia. "Fund shareholders of Regeneron Pharmaceuticals, Inc.". https://titelia.com/en/stocks/regeneron-pharmaceuticals-inc-US75886F1075